|
Chapter I: Executive Summary
- Background
- Scope and Methodology
- Size and Growth of Market
- Competitive Picture
- Market Trends and Factors
Chapter II: Introduction
- Background
- Diagnostics and Their Use
- Clinical relevance
- Scientific Limitations
- Cost-Benefit Relationships
- Major Influencing Technologies
- Genetics
- Genomics
- Proteomics
Chapter III: Molecular Diagnostics Technologies
- Background
- Amplification Technologies
- Blotting Technologies
- Electrophoretic Technologies
- Microchip Technologies
- Probe Technologies
- RNAi Analysis
- Single Nucleotide Polymorphism (SNP) Analysis
Chapter IV: Applications of Molecular Diagnostics
- The Testing Environment
- Commercial Laboratories
- University/Hospital Laboratories
- Blood Banking Analysis
- Cancer Diagnosis and Treatment Selection
- Genetic Diseases
- Pharmacogenetics
- Pharmacogenomics
Chapter V: The Market for Molecular Diagnostics
- Market Size and Trending
- Competitive Picture and Industry Structure
- Future Prospects
- Chapter VI: Company Profiles
- Abbott Diagnostics
- Affymetrix Inc.
- Agilent Technologies, Inc.
- Applied Biosystems Group
- Cepheid, Inc.
- Chiron Corporation
- diaDexus LLC
- Digene Corp.
- Gene Logic, Inc.
- Gen-Probe Incorporated
- Innogenetics NV
- MitoKor, Inc.
- Molecular Diagnostics, Inc.
- Myriad Genetics, Inc.
- Nanogen, Inc.
- Orchid Biosciences, Inc.
- Perkin-Elmer Corp.
- Roche Diasgnostics Division/Roche Molecular Systems
- Sangtec AB
- Visible Genetics
Chapter VII: Conclusions and Strategic Implications
APPENDIX A: Glossary
APPENDIX B: Company Names and Addresses | 
View Cart
